A high number of patients in a study who underwent transcatheter aortic valve replacement (TAVR) experienced severe and moderate cases of prosthesis-patient mismatch (PPM), meaning the implanted heart valve is too small for the patient, which can lead to inadequate blood flow. The research team from Penn Medicine also found that the risk of death and of heart failure readmissions were 19 percent and 12 percent higher, respectively, after one year as compared to patients without severe PPM.
Two-year results of the Moderato I Study demonstrated immediate, substantial and sustained reduction in blood pressure when BackBeat cardiac neuromodulation therapy (CNT) was used in patients with persistent hypertension (office BP > 150 mmHg). Patients in the study had persistent hypertension despite two or more anti-hypertensive medications and an indication for a pacemaker.
Intravascular ultrasound (IVUS) guidance improved clinical outcomes over angiography guidance during drug-eluting stent (DES) implantation by lowering the rate of target vessel failure at one year in the ULTIMATE trial.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
October 2, 2018 — GE Healthcare announced an equity investment in SonoSim, which specializes in ultrasound education and ...
Cindy Grines, M.D., chair and professor, department of cardiology, Zucker School of Medicine, Hostra/Northwell, spoke on ...
Ashish Pershad, M.D., medical director, structural heart program, Banner University Medical Heart Institute, Phoenix ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
October 1, 2018 — Recent results from the BIONYX randomized clinical study showed the novel, thin-strutted, polymer ...
Boston Scientific announced that the U.S. Food and Drug Administration (FDA) has approved its Premarket Approval (PMA) application to market the Eluvia Drug-Eluting Vascular Stent System, specifically developed for the treatment of peripheral artery disease (PAD). The Eluvia stent utilizes a drug-polymer combination to offer sustained release of the drug paclitaxel for a one-year timeframe, designed to prevent tissue regrowth that might otherwise block the stented artery.
October 1, 2018 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
New results from the RENASCENT studies presented at the Transcatheter Cardiovascular Therapeutics (TCT) conference showed Amaranth Medical’s Magnitude sirolimus-eluting bioresorbable scaffold (BRS) continued to perform well clinically at nine months.
Nevin Kapur, M.D., FAHA, FACC, FSCAI, executive director, Cardiovascular Center for Research and Innovation, Tufts ...
Heart failure patients who received the Carillon Mitral Contour System in the REDUCE FMR clinical trial showed a statistically significant reduction in regurgitant volume at one year compared to the control cohort receiving guideline-directed medical therapy. Results of the REDUCE FMR trial were presented at the 2018 Transcatheter Cardiovascular Therapeutics (TCT) conference, Sept. 21-25 in San Diego.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
Clarius Mobile Health is introducing the Clarius Cart at the American College of Emergency Physicians (ACEP) 2018 Scientific Assembly, Oct. 1-4 in San Diego. The Clarius Cart is an ultrasound accessory to complement the company’s lineup of wireless ultrasound scanners for use in more traditional settings. It is a mobile cart with a lockable cabinet to hold scanners, a working space for procedures, and a charging dock for scanner batteries and smart devices. It is designed for hospital and clinical environments to give clinicians the flexibility of personal ultrasound with the utility of traditional cart-based systems, without any cables.
September 28, 2018 — At one year following transcatheter aortic valve replacement (TAVR), implantation with the Portico ...
September 28, 2018 — Artificial intelligence (AI) driven by machine learning (ML) algorithms is a branch in the field of ...